Meta-analysis of the effectiveness and safety of vedolizumab for ulcerative colitis

doi:10.3748/wjg.v21.i20.6352

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 20

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7135)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-3) series.

Item

Count

PDF

554

WORD

186

HTML

3738

Figures (1-6)

135

Tables (1-3)

105

Sum=4718

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1097

Download

1320

Sum=2417

May 28, 2015 (publication date) through Apr 23, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Gastroenterol. May 28, 2015; 21(20): 6352-6360
Published online May 28, 2015. doi: 10.3748/wjg.v21.i20.6352

Full Size Figure Download Figure

Figure 3 Forest plots of the meta-analysis of clinical response rate. A: Pooled of all intervention groups; B: Drug dose: 2 mg/kg; C: Drug dose: 6 mg/kg.

Citation: Jin Y, Lin Y, Lin LJ, Zheng CQ. Meta-analysis of the effectiveness and safety of vedolizumab for ulcerative colitis. World J Gastroenterol 2015; 21(20): 6352-6360
URL: https://www.wjgnet.com/1007-9327/full/v21/i20/6352.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i20.6352